4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001593968-24-001096
SVP, General Counsel gave up 28,310 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Douglas Earl Martin SVP, General Counsel | 2024-08-21 | Shares withheld for taxes | −28,310 | $2.79 | $78,843 | 449,324 | D |
Loading xslF345X05/primary_01.xml…